Platismatia glauca —Lichen species with suppressive properties on migration and invasiveness of two different colorectal carcinoma cell lines
- 1 February 2022
- journal article
- research article
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (7) , e14096
Abstract
Platismatia glauca is a popular lichen traditionally used as a spice and possesses significant anti-cancer potential, whose anti-migratory/anti-invasive properties were mostly disregarded. Migration/invasion of cancer cells is processed in cancer metastasis and targeting their markers is an important strategy in anti-cancer treatment. We examined the anti-migratory/anti-invasive properties of P. glauca extract on two colorectal carcinoma cell lines (HCT-116 and SW-480) and elucidated possible mechanisms underlying these properties. Cell migration was evaluated by wound healing and RTCA methods. Immunofluorescent assay was used for the analysis of protein, while qRT-PCR for gene expression of migratory/invasive markers. ELISA assay was applied for the determination of MMP-9 concentration. P. glauca extract inhibited the motility of tested cells, by reducing pro-migratory/pro-invasive markers and potentially retaining intercellular connections. Treatment showed cell-selective effects, and HCT-116 cells were more responsive. Our study presents important scientific novelty, thus these lichen properties should be furtherly examined regarding the amelioration of anti-cancer treatment. Practical applications Based on the evidence we provided in the present study, we have demonstrated that lichen species Platismatia glauca possess important biological activity, which has not been sufficiently investigated so far. It is of great importance to explore its anti-cancer potential, not only from a cytotoxic point of view but especially anti-migratory and anti-invasive. Herein, we showed that this species expresses significant suppressive effects on migration and invasiveness of colorectal carcinoma cells. This tested lichen has the potential to be used as a natural complementary anti-cancer treatment, with special reference on the dose applied and type of carcinoma. Our study represents a significant novelty in the field of scientific investigation of lichens and natural products, and further detailed studies are needed on in vitro and in vivo model systems.Keywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (451‐03‐9/2021‐14/200122, 451‐03‐9/2021‐14/200378)
This publication has 24 references indexed in Scilit:
- Cytotoxic, antimigratory, pro-and antioxidative activities of extracts from medicinal mushrooms on colon cancer cell linesArchives of Biological Sciences, 2016
- Therapy with Plasma Purified Alpha1-Antitrypsin (Prolastin®) Induces Time-Dependent Changes in Plasma Levels of MMP-9 and MPOPLOS ONE, 2015
- Parmeliaceae family: phytochemistry, pharmacological potential and phylogenetic featuresRSC Advances, 2014
- Biological activities of Pseudevernia furfuracea (L.) Zopf extracts and isolation of the active compoundsJournal of Ethnopharmacology, 2012
- NIH Image to ImageJ: 25 years of image analysisNature Methods, 2012
- Biopharmaceutical potential of lichensPharmaceutical Biology, 2012
- Snail silencing effectively suppresses tumour growth and invasivenessOncogene, 2006
- Screening the antioxidant and antimicrobial properties of the lichens Parmelia saxatilis, Platismatia glauca, Ramalina pollinaria, Ramalina polymorpha and Umbilicaria nylanderianaPhytomedicine, 2006
- Tumoricidal Activity of Endothelial CellsJournal of Biological Chemistry, 2001
- β-Catenin mutations in cell lines established from human colorectal cancersProceedings of the National Academy of Sciences, 1997